Report Highlights
The global market for pharmaceutical filtration was valued at $10.4 billion in 2023. The market is estimated to grow from $11.4 billion in 2024 to $18.1 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2029.
Report Includes
- 67 data tables and 45 additional tables
- An analysis of the global markets for pharmaceutical filtration
- Analyses of global market trends, with market revenue data (sales figures) for 2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the market size and revenue forecasts for the pharmaceutical filtration market, with market share analysis by type, product, mechanism, category, technology, application and region
- Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
- Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
- Competitive intelligence, including companies’ market shares, recent M&A activity and venture funding
- Profiles of the leading companies, including Merck KGaA, 3M Co., Parker Hannifin Corp., Repligen Corp., and Asahi Kasei Corp.
Report Scope
In this report on the global pharmaceutical filtration market, the market is defined and analyzed on the basis of type (sterile, non-sterile), product (filters, systems, others), mechanism (surface filtration, depth filtration, cross-flow filtration), category (liquid and gas filtration, air filtration), technology (ultrafiltration, microfiltration, nanofiltration, others), and application (drug manufacturing, purification, quality control). By region, the market is categorized into North America, Europe, Asia-Pacific, and the Rest of the World. The base year for the market study is 2023, and the estimates and forecasts are for 2024 through 2029. The market estimates are provided in millions of U.S. dollars.
Report Synopsis
Report Metrics | Details | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2023 | ||||||||||||
Forecast period considered | 2024-2029 | ||||||||||||
Base year market size | $10.4 billion | ||||||||||||
Market size forecast | $18.1 billion | ||||||||||||
Growth rate | CAGR of 9.8% from 2024 to 2029 | ||||||||||||
Units considered | $ Millions | ||||||||||||
Segments covered | By Type, Product, Mechanism, Category, Technology, Application, and Region | ||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and the Rest of the World (RoW) | ||||||||||||
Key Market Drivers |
|
||||||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
- Macro factor: prevalence of chronic diseases.
- Growth of biopharmaceuticals industry.
- Regulatory compliance.
- Rising demand for personalized medicines.
- Technology integration in drug manufacturing.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global pharmaceutical filtration market should reach $9.4 billion by 2022 and more than $18.9 billion by 2027, with a compound annual growth rate (CAGR) of 14.9% during the forecast period of 2022-2027.
Report Includes
- 140 data tables and 21 additional tables
- An up-to-date overview and analysis of the global markets for pharmaceutical filtration
- Analyses of the global market trends, with market revenue (sales data) for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and upcoming market opportunities for pharmaceutical filtration, and areas of focus to forecast this market into various segments and sub-segments
- Evaluation and forecast the actual market size for pharmaceutical filtration technology, and corresponding market share analysis segmented by technology, filtration type, product type, system, type of filter media, application, and region
- Assessment of the technological, economic and business considerations of the pharmaceutical filtration industry with descriptions of market forces relevant to the pharmaceutical filtration and their areas of application
- Emphasis on the global and segmental pricing analysis of pharmaceutical filtration, industry trends and overview, and Covid-19 impact analysis
- Updated information on the key merger and acquisition deals, partnerships, collaborations and joint ventures as well as other strategic alliances within the pharmaceutical filtration industry
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Company profiles of major players within the industry, including 3M, Asahi Kasei Corp., Merck KGAA, Parker Hannifin Corp. and Thermo Fisher Scientific
Related Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Global Market for Membrane Microfiltration
The global microfiltration membranes market reached $3.9 billion in 2022 and should reach $6 billion by 2027, with a compound annual growth rate (CAGR) of 8.8% during the forecast period of 2022-2027.
Sterile Filtration Market for Lifescience
The global sterile filtration market should reach $5.3 billion by 2027 from $3.0 billion in 2022 at a compound annual growth rate (CAGR) of 12.0% for the forecast period of 2022 to 2027.
Membrane Bioreactors: Global Markets
The global market for membrane bioreactors should grow from $2.5 billion in 2021 to $4.1 billion by 2026 with a compound annual growth rate (CAGR) of 10.5% for the period of 2021-2026.
Recent Reports
Major Reverse Osmosis System Components for Water Treatment: The Global Market
The global market for RO system components is expected to grow from $18.8 billion in 2024 and is projected to reach $32.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.
Ultrafiltration Membranes: Technologies and Global Markets
The global market for ultrafiltration membranes was valued at $4.9 billion in 2023. The market is expected to grow from $5.2 billion in 2024 to $8.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2029.
Pharmaceutical Filtration: Global Markets
The global market for pharmaceutical filtration was valued at $10.4 billion in 2023. The market is estimated to grow from $11.4 billion in 2024 to $18.1 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2029.
Water Filtration: Global Markets
The global market for water filtration is expected to grow from $10.5 billion in 2024 and is projected to reach $19.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2029.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $17.4 billion in 2023 to reach $25.7 billion by 2028, at a compound annual growth rate (CAGR) of 8.1% from 2023 through 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More